Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

STAAR Surgical Company (STAA)

NGM · Medical Instruments & Supplies

$22.66-0.29 (-1.26%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$1.13B
P/E (TTM)
EPS
$-0.41
Div Yield
52W Range
$15.59–$35.87
Beta
1.23

Company overview

Next earnings: 2026-08-12(15d)

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists. The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Peers in Medical Instruments & Supplies

All in industry →

Recent press releases

STAAR Surgical Company has not issued a press release in this window.

SEC filings

All filings →

STAAR Surgical Company has not filed an SEC document in this window.

STAAR Surgical Company has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
7,360,335 sh+1.4%
2,472,390 sh+105.3%
2,076,743 sh+112.7%
4,226,563 sh-1.0%
15,019,491 sh+11.1%
67,862 sh-89.7%
668,222 sh● NEW
466,607 sh-48.9%

People at STAAR Surgical Company

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$11.4M
NI -$54.2M
06/25
$5.3M
NI -$16.8M
09/25
$94.7M
NI $8.9M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.18
Prior: $-0.34
Revenue sparkline